Patents by Inventor Everett Webster

Everett Webster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS INCLUDING SBI ADJUVANTS AND METHODS OF USE THEREOF
    Publication number: 20240082388
    Abstract: Disclosed herein are fusion polypeptides comprising: (i) a fragment antigen comprising an epitope of a target protein antigen; and (ii) a complement binding polypeptide. The disclosure also provides fusion polynucleotides (e.g., mRNA) encoding the same. Also disclosed herein are methods of making and using the fusion polypeptides and fusion polynucleotides of the present disclosure.
    Type: Application
    Filed: August 18, 2023
    Publication date: March 14, 2024
    Inventors: Kyle Backman, Nikhil Dhar, Nikolai Eroshenko, Taylor Gill, Kemo Jammeh, Marianna Keaveney, Justin Quinn, Hannu Rajaniemi, Everett Webster
  • MODIFIED RIBONUCLEIC ACIDS AND USES THEREOF
    Publication number: 20240026361
    Abstract: Disclosed herein is a modified ribonucleotide comprising a nucleoside comprising N4-acetylcytidine and/or 5-hydroxymethyluridine, and polyribonucleotides comprising the same. Also provided herein are compositions comprising a polyribonucleotide of the present disclosure and methods of making and using the same.
    Type: Application
    Filed: August 17, 2023
    Publication date: January 25, 2024
    Inventors: Nikhil Dhar, Marianna Keaveney, Kyle Backman, Everett Webster, Nikolai Eroshenko, Justin Quinn
  • MODIFIED RIBONUCLEIC ACIDS AND USES THEREOF
    Publication number: 20230407306
    Abstract: Disclosed herein is a modified ribonucleotide comprising a nucleoside comprising N4-acetylcytidine and/or 5-hydroxymethyluridine, and polyribonucleotides comprising the same. Also provided herein are compositions comprising a polyribonucleotide of the present disclosure and methods of making and using the same.
    Type: Application
    Filed: August 17, 2023
    Publication date: December 21, 2023
    Inventors: Nikhil Dhar, Marianna Keaveney, Kyle Backman, Everett Webster, Nikolai Eroshenko, Justin Quinn
  • Compositions including SBI adjuvants and methods of use thereof
    Patent number: 11771758
    Abstract: Disclosed herein are fusion polypeptides comprising: (i) a fragment antigen comprising an epitope of a target protein antigen; and (ii) a complement binding polypeptide. The disclosure also provides fusion polynucleotides (e.g., mRNA) encoding the same. Also disclosed herein are methods of making and using the fusion polypeptides and fusion polynucleotides of the present disclosure.
    Type: Grant
    Filed: March 3, 2022
    Date of Patent: October 3, 2023
    Assignee: Helix Nanotechnologies, Inc.
    Inventors: Kyle Backman, Nikhil Dhar, Nikolai Eroshenko, Taylor Gill, Kemo Jammeh, Marianna Keaveney, Justin Quinn, Hannu Rajaniemi, Everett Webster
  • MODIFIED RIBONUCLEIC ACIDS AND USES THEREOF
    Publication number: 20230203488
    Abstract: Disclosed herein is a modified ribonucleotide comprising a nucleoside comprising N4-acetylcytidine and/or 5-hydroxymethyluridine, and polyribonucleotides comprising the same. Also provided herein are compositions comprising a polyribonucleotide of the present disclosure and methods of making and using the same.
    Type: Application
    Filed: December 5, 2022
    Publication date: June 29, 2023
    Inventors: Nikhil Dhar, Marianna Keaveney, Kyle Backman, Everett Webster, Nikolai Eroshenko, Justin Quinn
  • Modified ribonucleic acids and uses thereof
    Patent number: 11639501
    Abstract: Disclosed herein is a modified ribonucleotide comprising a nucleoside comprising N4-acetylcytidine and/or 5-hydroxymethyluridine, and polyribonucleotides comprising the same. Also provided herein are compositions comprising a polyribonucleotide of the present disclosure and methods of making and using the same.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: May 2, 2023
    Assignee: Helix Nanotechnologies, Inc.
    Inventors: Nikhil Dhar, Marianna Keaveney, Kyle Backman, Everett Webster, Nikolai Eroshenko, Justin Quinn
  • MODIFIED RIBONUCLEIC ACIDS AND USES THEREOF
    Publication number: 20220372477
    Abstract: Disclosed herein is a modified ribonucleotide comprising a nucleoside comprising N4-acetylcytidine and/or 5-hydroxymethyluridine, and polyribonucleotides comprising the same. Also provided herein are compositions comprising a polyribonucleotide of the present disclosure and methods of making and using the same.
    Type: Application
    Filed: May 4, 2022
    Publication date: November 24, 2022
    Inventors: Nikhil Dhar, Marianna Keaveney, Kyle Backman, Everett Webster, Nikolai Eroshenko, Justin Quinn
  • COMPOSITIONS INCLUDING SBI ADJUVANTS AND METHODS OF USE THEREOF
    Publication number: 20220362373
    Abstract: Disclosed herein are fusion polypeptides comprising: (i) a fragment antigen comprising an epitope of a target protein antigen; and (ii) a complement binding polypeptide. The disclosure also provides fusion polynucleotides (e.g., mRNA) encoding the same. Also disclosed herein are methods of making and using the fusion polypeptides and fusion polynucleotides of the present disclosure.
    Type: Application
    Filed: March 3, 2022
    Publication date: November 17, 2022
    Inventors: Kyle Backman, Nikhil Dhar, Nikolai Eroshenko, Taylor Gill, Kemo Jammeh, Marianna Keaveney, Justin Quinn, Hannu Rajaniemi, Everett Webster